Inventor
SPERL GERHARD
US20 patents
⚠️ This page may combine multiple inventors who share the name “SPERL GERHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELL PATHWAYS INC
19 patentsUS6348032B1Feb 19, 2002
Method of inhibiting neoplastic cells with benzimidazole derivatives
CELL PATHWAYS INC117 citations97
US6211177B1Apr 3, 2001
Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives
CELL PATHWAYS INC86 citations97
US6180629B1Jan 30, 2001
[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
CELL PATHWAYS INC28 citations92
US6121321ASep 19, 2000
Substituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesions
CELL PATHWAYS INC26 citations92
US6071934AJun 6, 2000
Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
CELL PATHWAYS INC25 citations92
US6063818AMay 16, 2000
Substituted benzylidene indenyl formamides, acetamides and propionamides
CELL PATHWAYS INC32 citations92
US6028116AFeb 22, 2000
Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia
CELL PATHWAYS INC29 citations92
US5965619AOct 12, 1999
Method for treating patients having precancerous lesions with substituted indene derivatives
CELL PATHWAYS INC47 citations92
US5696159ADec 9, 1997
Lactone compounds for treating patients with precancerous lesions
CELL PATHWAYS INC35 citations92
US6486158B1Nov 26, 2002
[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia
CELL PATHWAYS INC17 citations84
US6420410B1Jul 16, 2002
Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-ones
CELL PATHWAYS INC17 citations83
US6403831B1Jun 11, 2002
Substituted benzylidene indenyl formamides, acetamides and propionamides
CELL PATHWAYS INC13 citations74
US6300346B1Oct 9, 2001
Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions
CELL PATHWAYS INC7 citations74
US5998477ADec 7, 1999
Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions
CELL PATHWAYS INC7 citations74
US6160003ADec 12, 2000
1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia
CELL PATHWAYS INC5 citations63
US5939417AAug 17, 1999
1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia
CELL PATHWAYS INC2 citations63
US5776962AJul 7, 1998
Lactone compounds for treating patient with precancerous lesions
CELL PATHWAYS INC3 citations63
US6020379AFeb 1, 2000
Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
CELL PATHWAYS INC2 citations62
US6455703B2Sep 24, 2002
1,3,6,-Trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia
CELL PATHWAYS INC0 citations42